Savior Lifetec Corporation (4167.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$20.60 (-1.44%) as of
Key statistics
- Market cap
- 6.83B
- P/E (TTM)
- 7.13
- EPS (TTM)
- 2.89
- Dividend yield
- 3.85%
- 52-week range
- 15.64 – 23.95
- Beta
- 0.11
- Revenue (TTM)
- 1.12B
- Profit margin
- 91.92%
- Volume
- 1.78M
About Savior Lifetec Corporation
Savior Lifetec Corporation engages in the research, development, design, manufacture, and sale of carbapenem generics in the Americas, Asia, Taiwan, Europe, and internationally. The company offers injection generics, controlled-release generics, the development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms. It also provides medicine manufacturer technology and services. In addition, the company sells antibacterial raw materials and injectables. Savior Lifetec Corporation was founded in 1993 and is headquartered in Tainan City, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Tainan City, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.